Exchange: NASDAQ·Updated 07:30 PM EDT

KARD Kardigan Inc.

$19.08
$0.56
(2.78%)
Today
Closed $19.60
$0.5176
(2.64%)
After Hours
Reported EarningsAug 11
Mkt Cap$1.89B
Vol327,113.00

About KARD

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
42

Bearish Sentiment

How do you feel about KARD?

Advertisement|Remove ads.